FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $179,782,000 | +189.6% | 9,011,651 | 0.0% | 3.84% | +131.7% |
| Q2 2022 | $62,090,000 | -25.9% | 9,011,651 | 0.0% | 1.66% | -9.5% |
| Q1 2022 | $83,808,000 | -34.6% | 9,011,651 | 0.0% | 1.83% | -19.0% |
| Q4 2021 | $128,146,000 | -38.7% | 9,011,651 | 0.0% | 2.26% | -22.0% |
| Q3 2021 | $208,980,000 | -6.8% | 9,011,651 | 0.0% | 2.90% | -19.6% |
| Q2 2021 | $224,300,000 | -11.2% | 9,011,651 | 0.0% | 3.60% | -5.4% |
| Q1 2021 | $252,506,000 | -19.7% | 9,011,651 | 0.0% | 3.81% | -13.4% |
| Q4 2020 | $314,507,000 | -30.0% | 9,011,651 | 0.0% | 4.40% | -46.5% |
| Q3 2020 | $449,141,000 | +7.2% | 9,011,651 | 0.0% | 8.22% | +0.6% |
| Q2 2020 | $418,952,000 | – | 9,011,651 | – | 8.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EDBI Pte Ltd | 1,268,805 | $8,742,000 | 8.10% |
| Samsara BioCapital, LLC | 1,565,526 | $10,786,000 | 2.88% |
| Deep Track Capital, LP | 4,050,000 | $27,905,000 | 1.83% |
| RA Capital Management | 9,011,651 | $62,090,000 | 1.66% |
| Cormorant Asset Management, LP | 3,172,204 | $21,856,000 | 1.65% |
| ARMISTICE CAPITAL, LLC | 4,736,000 | $32,631,000 | 0.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 94,386 | $650,000 | 0.20% |
| Parkman Healthcare Partners LLC | 78,603 | $542,000 | 0.20% |
| Integral Health Asset Management, LLC | 130,051 | $896,000 | 0.18% |
| Opaleye Management Inc. | 58,700 | $404,000 | 0.18% |